1. Home
  2. SONO vs XNCR Comparison

SONO vs XNCR Comparison

Compare SONO & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

N/A

Current Price

$17.12

Market Cap

1.9B

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$33.57

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SONO
XNCR
Founded
2002
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
SONO
XNCR
Price
$17.12
$33.57
Analyst Decision
Buy
Buy
Analyst Count
4
14
Target Price
$18.63
★ $43.83
AVG Volume (30 Days)
★ 1.6M
1.5M
Earning Date
11-10-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 243.14
65.36
EPS
★ 0.73
N/A
Revenue
★ $1,546,890,000.00
$125,576,000.00
Revenue This Year
$6.93
$58.19
Revenue Next Year
$6.75
N/A
P/E Ratio
$23.38
★ N/A
Revenue Growth
7.18
★ 13.65
52 Week Low
$12.44
$10.38
52 Week High
$19.82
$40.60

Technical Indicators

Market Signals
Indicator
SONO
XNCR
Relative Strength Index (RSI) 48.96 54.03
Support Level $16.70 $22.80
Resistance Level $17.19 $33.60
Average True Range (ATR) 0.99 2.08
MACD -0.01 -0.54
Stochastic Oscillator 40.87 35.21

Price Performance

Historical Comparison
SONO
XNCR

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: